feed,title,long_url,short_url
Benzinga,argenx to Present at Upcoming Investor Conferences,https://benzinga.com/node/32640734,https://da.gd/8xDwmj
Benzinga,Press Release: Positive Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis,https://benzinga.com/node/32640733,https://da.gd/Xbmga3
